Espline SARS-COV-2&Flu A+B (Q3B03T)
Japan·IVD·IVD·Updated November 21, 2023- English
- 鼻咽頭ぬぐい液又は鼻腔ぬぐい液中のＳＡＲＳ-ＣｏＶ-２抗原、 Ａ型インフ ルエンザウイルス抗原及びＢ型インフルエンザウイルス抗原の検出 （ＳＡＲＳ-ＣｏＶ-２感染又はインフルエンザウイルス感染の診断補助）
- 日本語 (Japanese)
- 鼻咽頭ぬぐい液又は鼻腔ぬぐい液中のＳＡＲＳ-ＣｏＶ-２抗原、 Ａ型インフ ルエンザウイルス抗原及びＢ型インフルエンザウイルス抗原の検出 （ＳＡＲＳ-ＣｏＶ-２感染又はインフルエンザウイルス感染の診断補助）
- Device Type
- IVD
- Device Class
- IVD
- Class Name (English)
- Influenza Virus Kit
- Class Name (日本語)
- インフルエンザウイルスキット
- PMDA ID
- 670773_30300EZX00068000_A_03_01
- Last Update Date
- November 21, 2023
- Official Documents
- View PDF (PMDA)
- English
- Fujirebio Corporation
- 日本語 (Japanese)
- 製造販売／富士レビオ株式会社
Access comprehensive regulatory information for Espline SARS-COV-2&Flu A+B (Q3B03T) (エスプライン ＳＡＲＳ-ＣｏＶ-２＆Ｆｌｕ Ａ＋Ｂ (Q3B03T)) in the Japan medical device market through Pure Global AI's free bilingual database. This IVD medical device is registered under PMDA ID 670773_30300EZX00068000_A_03_01 and manufactured by Fujirebio Corporation. The device information was last updated on November 21, 2023.
This page provides complete registration details including device class (IVD), classification (Influenza Virus Kit / インフルエンザウイルスキット), manufacturer information (English and Japanese), intended use, and regulatory compliance data from the official Japan PMDA medical device database. Pure Global AI offers free bilingual access to Japan's complete medical device registry, helping global MedTech companies navigate PMDA regulations efficiently.